Before or After: Evolving Neoadjuvant Approaches to Locally Advanced Non-Small Cell Lung Cancer.

about

Before or After: Evolving Neoadjuvant Approaches to Locally Advanced Non-Small Cell Lung Cancer.

Item

http://www.wikidata.org/entity/Q49256406

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Before or After: Evolving Neoa ...... ed Non-Small Cell Lung Cancer.

@en

Before or After: Evolving Neoa ...... ed Non-Small Cell Lung Cancer.

@nl

type

Item

label

Before or After: Evolving Neoa ...... ed Non-Small Cell Lung Cancer.

@en

Before or After: Evolving Neoa ...... ed Non-Small Cell Lung Cancer.

@nl

prefLabel

Before or After: Evolving Neoa ...... ed Non-Small Cell Lung Cancer.

@en

Before or After: Evolving Neoa ...... ed Non-Small Cell Lung Cancer.

@nl

P1476

Before or After: Evolving Neoa ...... ed Non-Small Cell Lung Cancer.

@en

P2093

Erin A Gillaspie

http://www.w3.org/2001/XMLSchema#string

Evan C Osmundson

http://www.w3.org/2001/XMLSchema#string

Jennifer Lewis

http://www.w3.org/2001/XMLSchema#string

Leora Horn

http://www.w3.org/2001/XMLSchema#string

P2860

Postoperative radiotherapy for non-small cell lung cancer.

Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2 non-small-cell lung cancer: a multicenter phase II trial.

Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).

Carboplatin and paclitaxol (Taxol) as an induction regimen for patients with biopsy-proven stage IIIA N2 non-small cell lung cancer. an EORTC phase II study (EORTC 08958).

Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA-bulky N2 and Stage IIIB nonsmall cell lung carcinoma: an Italian Lung Cancer Project Observational Study.

Gemcitabine, paclitaxel, and cisplatin as induction chemotherapy for patients with biopsy-proven Stage IIIA(N2) nonsmall cell lung carcinoma: a Phase II multicenter study.

Pilot study of neoadjuvant ifosfamide, cisplatin, and etoposide in locally advanced non-small cell lung cancer.

Randomized phase 2 trial on refinement of early-stage NSCLC adjuvant chemotherapy with cisplatin and pemetrexed versus cisplatin and vinorelbine: the TREAT study.

Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study.

Phase 2 trial of neoadjuvant bevacizumab plus pemetrexed and carboplatin in patients with unresectable stage III lung adenocarcinoma (GASTO 1001).

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FONC.2018.00005

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29410947

http://www.w3.org/2001/XMLSchema#string

P932

5787144

http://www.w3.org/2001/XMLSchema#string